Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A thorough assessment by qualified professionals is essential
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
To that end, penetration rates are the key swing factor
Your body is constantly trying to maintain balance, and as your weight changes, it adjusts hunger, metabolism, and energy use to keep your weight stable
I can wear a bikini now and actually feel good about myself
At HaloScrips, we evaluate GLP-1 spends quarterly
